Position
Fidelity in Capricor Therapeutics, Inc.
Back to the book · All holders of CAPR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$4.88M$30.40 → $24.08
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 922.6K | $26.6M | — | — | — | 0.0% |
| Q1 2026 | 772.6K | $23.5M | $30.40 | $1.19M | −$4.33M | 0.0% |
| Q2 2026 | 1.14M | $27.4M | $24.08 | −$4.88M | $8.79M | 0.0% |